Sequella
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9610 Medical Center Dr Ste 200, Rockvill...Phone Number
(301) 762-7776Website
www.sequella.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sequella
Sequella is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline targets significant global health issues, particularly tuberculosis (TB) and its multidrug-resistant forms, which impact over 3 billion people worldwide. With drug candidates like SQ109 and sutezolid having completed phase 2 clinical trials, Sequella aims to address the urgent need for effective treatments in this area. The company also explores therapies for other serious infections, including those caused by Clostridium difficile and various parasitic diseases.Explore more
Sequella Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sequella your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sequella is spiking on competitors!
Sequella, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Sequella had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sequella has new funding data
Product Launch: Get notified when Sequella launches new products
Congratulate Masked Content for being promoted to Masked Content at Sequella
Earning: See what the market has to say on Sequella recently announced quarterly report
Check if Sequella has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Sequella
Find more new buyers
Compare Similar Companies to Sequella
Compare insights from companies similar to Sequella, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sequella is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sequella is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sequella.
Sequella financials insights
Gather financial insights about Sequella, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Debt
$2M
2011
Multiple Rounds
$1.6M
2012
Unspecified
$100K
2013
Unspecified
$555K
2014
Debt
$3.1M
2016
Private Equity
$1.7M
2017
Private Equity
$630K
Sequella Tech Stack
A closer look at the technologies used by Sequella
Sequella News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sequella
Sign Up For FreeTo access detailed company insights
Sequella is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline targets significant global health issues, particularly tuberculosis (TB) and its multidrug-resistant forms, which impact over 3 billion people worldwide. With d... Read More
